374 related articles for article (PubMed ID: 16054069)
21. Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity.
Ou HY; Wu HT; Hung HC; Yang YC; Wu JS; Chang CJ
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E668-76. PubMed ID: 23341496
[TBL] [Abstract][Full Text] [Related]
22. The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1.
Bergeron V; Ghislain J; Poitout V
Islets; 2016 Nov; 8(6):157-164. PubMed ID: 27700527
[TBL] [Abstract][Full Text] [Related]
23. GPR40 is partially required for insulin secretion following activation of beta3-adrenergic receptors.
Pang Z; Wu N; Zhang X; Avallone R; Croci T; Dressler H; Palejwala V; Ferrara P; Tocci MJ; Polites HG
Mol Cell Endocrinol; 2010 Aug; 325(1-2):18-25. PubMed ID: 20416356
[TBL] [Abstract][Full Text] [Related]
24. GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion.
Itoh Y; Hinuma S
Hepatol Res; 2005 Oct; 33(2):171-3. PubMed ID: 16214394
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.
Nagasumi K; Esaki R; Iwachidow K; Yasuhara Y; Ogi K; Tanaka H; Nakata M; Yano T; Shimakawa K; Taketomi S; Takeuchi K; Odaka H; Kaisho Y
Diabetes; 2009 May; 58(5):1067-76. PubMed ID: 19401434
[TBL] [Abstract][Full Text] [Related]
26. GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges.
Mohammad S
Curr Drug Targets; 2016; 17(11):1292-300. PubMed ID: 26648068
[TBL] [Abstract][Full Text] [Related]
27. A Single Amino Acid Mutation (R104P) in the E/DRY Motif of GPR40 Impairs Receptor Function.
Guo S; Zhang J; Zhang S; Li J
PLoS One; 2015; 10(10):e0141303. PubMed ID: 26505901
[TBL] [Abstract][Full Text] [Related]
28. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
Doshi LS; Brahma MK; Sayyed SG; Dixit AV; Chandak PG; Pamidiboina V; Motiwala HF; Sharma SD; Nemmani KV
Metabolism; 2009 Mar; 58(3):333-43. PubMed ID: 19217448
[TBL] [Abstract][Full Text] [Related]
29. Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice.
Du T; Yang L; Xu X; Shi X; Xu X; Lu J; Lv J; Huang X; Chen J; Wang H; Ye J; Hu L; Shen X
J Endocrinol; 2019 Feb; 240(2):195-214. PubMed ID: 30400036
[TBL] [Abstract][Full Text] [Related]
30. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
31. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.
Tomita T; Masuzaki H; Iwakura H; Fujikura J; Noguchi M; Tanaka T; Ebihara K; Kawamura J; Komoto I; Kawaguchi Y; Fujimoto K; Doi R; Shimada Y; Hosoda K; Imamura M; Nakao K
Diabetologia; 2006 May; 49(5):962-8. PubMed ID: 16525841
[TBL] [Abstract][Full Text] [Related]
32. Protective role of Pollen Typhae total flavone against the palmitic acid-induced impairment of glucose-stimulated insulin secretion involving GPR40 signaling in INS-1 cells.
Feng XT; Duan HM; Li SL
Int J Mol Med; 2017 Sep; 40(3):922-930. PubMed ID: 28731171
[TBL] [Abstract][Full Text] [Related]
33. Role of GPR40 in fatty acid action on the beta cell line INS-1E.
Shapiro H; Shachar S; Sekler I; Hershfinkel M; Walker MD
Biochem Biophys Res Commun; 2005 Sep; 335(1):97-104. PubMed ID: 16081037
[TBL] [Abstract][Full Text] [Related]
34. Acute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of islets.
Ayvaz G; Balos Törüner F; Karakoç A; Yetkin I; Cakir N; Arslan M
Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S7-12; discussion 3S108-12. PubMed ID: 12688627
[TBL] [Abstract][Full Text] [Related]
35. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
36. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
Itoh Y; Kawamata Y; Harada M; Kobayashi M; Fujii R; Fukusumi S; Ogi K; Hosoya M; Tanaka Y; Uejima H; Tanaka H; Maruyama M; Satoh R; Okubo S; Kizawa H; Komatsu H; Matsumura F; Noguchi Y; Shinohara T; Hinuma S; Fujisawa Y; Fujino M
Nature; 2003 Mar; 422(6928):173-6. PubMed ID: 12629551
[TBL] [Abstract][Full Text] [Related]
37. Physiology and therapeutics of the free fatty acid receptor GPR40.
Huang H; Dai MH; Tao YX
Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
[TBL] [Abstract][Full Text] [Related]
38. GPR40: a therapeutic target for mediating insulin secretion (review).
Feng XT; Leng J; Xie Z; Li SL; Zhao W; Tang QL
Int J Mol Med; 2012 Dec; 30(6):1261-6. PubMed ID: 23023155
[TBL] [Abstract][Full Text] [Related]
39. Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function.
Vilas-Boas EA; Karabacz N; Marsiglio-Librais GN; Valle MMR; Nalbach L; Ampofo E; Morgan B; Carpinelli AR; Roma LP
Pharmacol Rep; 2020 Dec; 72(6):1725-1737. PubMed ID: 32274767
[TBL] [Abstract][Full Text] [Related]
40. [Free fatty acid receptors and their physiological role in metabolic regulation].
Hirasawa A; Hara T; Ichimura A; Tsujimoto G
Yakugaku Zasshi; 2011; 131(12):1683-9. PubMed ID: 22129861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
